BofA raised the firm’s price target on IBM (IBM) to $335 from $315 and keeps a Buy rating on the shares. The firm, which sees a “tougher setup heading into 2026” after a strong year in 2025, rolls forward its valuation to calendar 2027 to better reflect the Confluent (CFLT) acquisition.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- Quantum Computing News: Federal Funding Push Signals Quantum’s Shift Toward Commercial Use
- Rigetti Stock (RGTI) Slips on 108-Qubit Quantum System Delay
- QBTS Stock Wins a Price Target Boost on Qubit Control and Error Correction Advances
- 3 Quantum Computing Stocks with Potential to Beat the Market – 1/9/2026
- AI Is Influencing Shoppers Before They Enter Stores, IBM Study Says